Porus GmbH – Trademark Portfolio

Entity Type: 99

Porus GmbH holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 29 (Meats & Processed Foods) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 3 are pending. Notable registered marks include CATNEY, DOGNEY, OSCATEC, and RENALTEC. The owner is based in Mohnheim.

Alfred-Bobel-Strasse 10

Creative Campus Mohnheim, Gebaeude A01

Mohnheim 40789 , DE

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Porus GmbH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (9 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

29
Meats & Processed Foods (2 filings)

Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits

Frequently Asked Questions

How many trademarks does Porus GmbH have?

Porus GmbH has 9 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 pending.

What trademark classes does Porus GmbH file in?

Porus GmbH files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Porus GmbH's most well-known trademarks?

Porus GmbH's registered trademark portfolio includes well-known marks such as CATNEY, DOGNEY, OSCATEC, and RENALTEC. These are among 4 currently registered trademarks in the portfolio.

What is Porus GmbH's trademark registration success rate?

Porus GmbH has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 3 applications are pending review.